Biogen Idec shares owned by Fairpointe Capital
Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Fairpointe Capital
from 13F filings
Historical chart of Fairpointe Capital investment in Biogen Idec
Tip: Access up to 7 years of quarterly data
All positions including Biogen Idec held by Fairpointe Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Biogen Idec by Fairpointe Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2021-03-31 | $309k | 1.1k | 279.70 |
2020-12-31 | $8.8M | 36k | 244.87 |